CLASS II ONGOING Drug recall · Reported 19 Mar 2025 · FDA Enforcement Report
Walgreens, Acne Control Cleanser recalled by Sigan Industries Group
Sigan Industries Group is recalling Walgreens, Acne Control Cleanser, 10% Benzoyl Peroxide/Acne Treatment, distributed nationwide in the US. The recall was initiated on 28 Feb 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0274-2025
- FDA event ID
- 96395
- Recalling firm
- Sigan Industries Group, Brampton
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 28 Feb 2025
- FDA classified
- 12 Mar 2025
- Reported
- 19 Mar 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Benzene
- Drug class
- Creams, Ointments & Gels
Timeline
| 28 Feb 2025 | Recall initiated by company | |
| 12 Mar 2025 | Classified by FDA | +12 days |
| 19 Mar 2025 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Chemical Contamination: Presence of benzene
Product as listed by the FDA
Walgreens, Acne Control Cleanser, 10% Benzoyl Peroxide/Acne Treatment, NET WT 5 OZ (142g) Distributed by: Walgreen CO, 200 Wilmont RD, Deerfield, IL, Made in Canada. UPC#: 1 9560203602 8
Where it was distributed
Nationwide in the U.S.A
Stores named: Walgreens
Questions about this recall
Why was it recalled?
Chemical Contamination: Presence of benzene
Which lots are affected?
Lot#: 23-09328, Exp.: 09/2025
Where was it sold?
Nationwide in the U.S.A
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.